Trial intelligence / Profile preview

Smecta for Gut Barrier Dysfunction in Henoch-Schönlein Purpura

ChiCTR-IPR-16008658Phase 4Not yet recruiting

Sponsor
West China Second University Hospital
Start
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of diosmectite in Henoch-Schönlein Purpura (HSP) (2 arms), sponsored by West China Second University Hospital. Primary endpoints: Diamine oxidase level, D-lactic acid level and 1 more. Planned start Jul 2016; status: not yet recruiting.

02

Drugs

diosmectite
03

Conditions

Henoch-Schönlein Purpura (HSP)

Beyond the preview

Go deeper on ChiCTR-IPR-16008658.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-16008658.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call